1986
DOI: 10.1016/0022-4804(86)90201-5
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of adenosine deaminase activity in patients with head and neck cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
2

Year Published

1990
1990
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 24 publications
0
13
2
Order By: Relevance
“…In contrast to these findings, ADA levels were depressed in cancerous laryngeal tissues [13] , low lymphocyte ADA activities were found in head and neck cancers [14] , and low salivary activities of ADA in patients with oral cancer [36] were observed.…”
Section: Discussioncontrasting
confidence: 46%
See 1 more Smart Citation
“…In contrast to these findings, ADA levels were depressed in cancerous laryngeal tissues [13] , low lymphocyte ADA activities were found in head and neck cancers [14] , and low salivary activities of ADA in patients with oral cancer [36] were observed.…”
Section: Discussioncontrasting
confidence: 46%
“…ADA activity is increased in diseases characterized by T-lymphocyte proliferation [5] and it is a nonspecific marker of T-cell activation. ADA plays an important role in many immunity-mediated diseases, and contradictory results have been reported regarding ADA levels in malignancies [6][7][8][9][10][11][12][13][14] .…”
Section: Introductionmentioning
confidence: 99%
“…ADA enzyme activities in head and neck cancer tissues have presented controversial results in literature review [15][16][17][18][19]. Altered purine metabolism in various cancer types which is affected actively by genetic alterations may be one of the reasons for this discrepancy [20].…”
Section: Discussionmentioning
confidence: 99%
“…Binding of ADA to CD26 is capable of reducing the local concentration of adenosine and has an enzymatic role in protecting T cells from an adenosine-mediated inhibition of proliferation [44, 45]. Indeed, it has been reported that adenosine deaminase activity is significantly lower in the peripheral lymphocytes of cancer patients, suggesting increased susceptibility of T cells to adenosine-mediated inhibition within the tumour microenvironment [46]. Moreover, cytotoxic T cells show very low levels of adenosine deaminase activity, leaving us to hypothesize that cytotoxic cells would be quite sensitive to the immune inhibitory effect of adenosine accumulated within tumours.…”
Section: Adenosine Inhibits Killer T Cell Activation Via A3 and A2a Smentioning
confidence: 99%